Christoph olpers has done his PhD in Molecular Biology from the University of Mainz, Germany, and an MBA from Bradford University, UK. He has almost 15 years of experience in Intellectual Property and Licensing. Before he joined the patent law firm, Michalski Hüttermann & Partners, Dusseldorf/Munich, as Senior Patent Consultant in early 2015, he was the Director IP Biologics of the Teva Pharmaceutical Industries for six years with global responsibility for innovative biologics and biosimilar products. He is the Founder of a biopharmaceutical consultancy firm, author of more than 20 publications and a member of the Licensing Executive Society   Christoph olpers has done his PhD in Molecular Biology from the University of Mainz, Germany, and an MBA from Bradford University, UK. He has almost 15 years of experience in Intellectual Property and Licensing. Before he joined the patent law firm, Michalski Hüttermann & Partners, Dusseldorf/Munich, as Senior Patent Consultant in early 2015, he was the Director IP Biologics of the Teva Pharmaceutical Industries for six years with global responsibility for innovative biologics and biosimilar products. He is the Founder of a biopharmaceutical consultancy firm, author of more than 20 publications and a member of the Licensing Executive Society  

Bioprinting